Ashok R Shaha

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi TNM classification of thyroid carcinoma
    Ashok R Shaha
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
    World J Surg 31:879-87. 2007
  2. ncbi Predictors of outcome for advanced-stage supraglottic laryngeal cancer
    Ian Ganly
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Head Neck 31:1489-95. 2009
  3. ncbi Incidence and significance of Delphian node metastasis in papillary thyroid cancer
    N Gopalakrishna Iyer
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York 10065, USA
    Ann Surg 253:988-91. 2011
  4. ncbi Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 21:501-4. 2011
  5. ncbi Lymph node density is a significant predictor of outcome in patients with oral cancer
    Ziv Gil
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 115:5700-10. 2009
  6. ncbi Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer
    Ramesh Rengan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 31:465-9. 2008
  7. ncbi Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma
    Benjamin E Saltman
    Department of Otolaryngology, Division of Head and Neck Surgery, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    Head Neck 32:1686-92. 2010
  8. ncbi Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 81:e207-13. 2011
  9. ncbi The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 150:1242-9. 2011
  10. ncbi Analysis of postoperative complications of open partial laryngectomy
    Ian Ganly
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Head Neck 31:338-45. 2009

Detail Information

Publications107 found, 100 shown here

  1. ncbi TNM classification of thyroid carcinoma
    Ashok R Shaha
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
    World J Surg 31:879-87. 2007
    ..The TNM staging system helps reporting our data and comparing results in different parts of the world. However, there is no level I evidence in thyroid cancer...
  2. ncbi Predictors of outcome for advanced-stage supraglottic laryngeal cancer
    Ian Ganly
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Head Neck 31:1489-95. 2009
    ..The objective of this study was to report our experience in the management of patients with advanced-stage supraglottic laryngeal carcinoma and to identify factors predictive of outcome...
  3. ncbi Incidence and significance of Delphian node metastasis in papillary thyroid cancer
    N Gopalakrishna Iyer
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York 10065, USA
    Ann Surg 253:988-91. 2011
    ..The objective of this study was to determine the incidence and significance of Delphian node (DN) metastasis in papillary thyroid cancer...
  4. ncbi Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 21:501-4. 2011
    ..3%). In contrast to earlier reports, death caused by central compartment disease in this recent series is very rare, with metastatic disease accounting for almost all fatalities...
  5. ncbi Lymph node density is a significant predictor of outcome in patients with oral cancer
    Ziv Gil
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 115:5700-10. 2009
    ..In the current study, the utility of lymph node density (LND) was evaluated as an alternative method for predicting survival...
  6. ncbi Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer
    Ramesh Rengan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 31:465-9. 2008
    ..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
  7. ncbi Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma
    Benjamin E Saltman
    Department of Otolaryngology, Division of Head and Neck Surgery, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    Head Neck 32:1686-92. 2010
    ..The goal of this study is to report the results of SLNB for head and neck cutaneous melanoma in locating the sentinel node and to report on the prognostic implications of SLNB for this cohort of patients...
  8. ncbi Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 81:e207-13. 2011
    ..However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated...
  9. ncbi The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 150:1242-9. 2011
    ....
  10. ncbi Analysis of postoperative complications of open partial laryngectomy
    Ian Ganly
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Head Neck 31:338-45. 2009
    ..The objective of this study was to report the incidence of postoperative complications for partial laryngectomy and to identify patient- and tumor-related factors predictive of postoperative complications...
  11. ncbi Delphian node metastasis in head and neck cancers--oracle or myth?
    N Gopalakrishna Iyer
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Surg Oncol 102:354-8. 2010
    ..In this article, we review the existing literature on the topic to determine the significance of DN metastasis in laryngeal, hypopharyngeal and thyroid cancers...
  12. ncbi Micromedullary thyroid cancer: how micro is truly micro?
    Venu G Pillarisetty
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 16:2875-81. 2009
    ..The aggressive nature of medullary thyroid cancer (MTC) is evidenced by its propensity to present early with lymph node (LN) metastases. The clinical significance of sporadic MTC < or =1 cm (micro-MTC) is not clearly defined...
  13. ncbi Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 22:3965-72. 2004
    ..A sequential approach to control for multiple comparisons and effect of confounding variables allows the identification of clinically relevant aberrations. The significance of each individual abnormality merits further consideration...
  14. ncbi Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx
    Ian Ganly
    Department of Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 132:59-66. 2006
    ..These patients have poorer survival outcomes manifested by local, regional, and distant disease progression...
  15. ncbi Thyroid isthmusectomy for well-differentiated thyroid cancer
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:767-70. 2011
    ..This study was designed to analyze outcomes in patients treated with isthmusectomy for small well-differentiated thyroid cancer (WDTC) at our institution...
  16. ncbi Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:795-801. 2009
    ..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
  17. ncbi Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
    N Gopalakrishna Iyer
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:4439-46. 2011
    ..The objective of this study was to evaluate patterns of RAI use and elevated risk of secondary primary malignancies (SPM) in patients with low-risk (T1N0) WDTC...
  18. ncbi Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma
    Ian Ganly
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:1369-76. 2007
    ..To identify genes related to angiogenesis/metastasis that predict locoregional failure in patients with laryngopharyngeal cancer (LPC) undergoing chemoradiotherapy (CRT) treatment...
  19. ncbi Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx
    Karen Lin
    Head and Neck Service, Department of Surgery, P. O. Box 285, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York 10021, USA
    Head Neck 27:1042-8. 2005
    ..CONCLUSIONS: The rates of SPMADT after treatment of SCCOC and SCCL are comparable, but the patterns are different. Smoking and alcohol use are independent predictors of SPMADT development...
  20. ncbi Contemporary management of cancer of the oral cavity
    Eric M Genden
    Department of Otolaryngology Head and Neck Surgery, The Mount Sinai Medical Center, New York, NY, USA
    Eur Arch Otorhinolaryngol 267:1001-17. 2010
    ..The purpose of this review is to discuss the most current management options for oral cavity cancers...
  21. ncbi Electronic synoptic operative reporting for thyroid surgery using an electronic data management system: potential for prospective multicenter data collection
    N Gopalakrishna Iyer
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:762-6. 2011
    ..Thyroid surgery lends itself to synoptic reporting, because there are a predefined number of essential intraoperative events and findings that every endocrine surgeon invariably records...
  22. ncbi Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
    David G Pfister
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 24:1072-8. 2006
    ..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
  23. ncbi Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer
    Yungpo Bernard Su
    Department of a Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer J 12:182-8. 2006
    ..To evaluate the ability of granulocyte-stimulating factor to decrease mucositis during postoperative radiotherapy for stage II-IV squamous head and neck cancer in a randomized, double-blind, placebo-controlled trial...
  24. ncbi Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
    Seng C Ong
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 48:501-7. 2007
    ..The role of (18)F-FDG PET in MTC remains somewhat unclear. We reviewed our own experience with (18)F-FDG PET in postthyroidectomy MTC patients with elevated calcitonin...
  25. ncbi Airway management in anaplastic thyroid carcinoma
    Ashok R Shaha
    Head and Neck Surgery, Cornell University Medical Center, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Laryngoscope 118:1195-8. 2008
    ..In patients who present with advanced anaplastic thyroid cancer, airway management is difficult because of bilateral vocal cord paralysis or tracheal invasion by the tumor. Airway management can be extremely complex in these patients...
  26. ncbi Current trends in initial management of laryngeal cancer: the declining use of open surgery
    Carl E Silver
    Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
    Eur Arch Otorhinolaryngol 266:1333-52. 2009
    ..While supracricoid laryngectomy has been employed for selected patients, total laryngectomy is the usual procedure for salvage of failure after non-surgical treatment...
  27. ncbi Surgical management of metastases to the thyroid gland
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:800-4. 2011
    ..Metastases to the thyroid gland are uncommon, with rates reported between 0.02% and 1.4% of surgically resected thyroid specimens. Our goal was to present our experience with surgical management of metastases to the thyroid gland...
  28. ncbi Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population
    Erik G Cohen
    Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Arch Otolaryngol Head Neck Surg 130:773-8. 2004
    ..The predictive value of a negative FNAB finding is low, and should not supersede clinical suspicion. Cytologic findings of a lymphocyte-predominant lesion should prompt further workup to rule out lymphoma...
  29. ncbi Radiotherapy after surgical resection for head and neck mucosal melanoma
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Am J Clin Oncol 33:281-5. 2010
    ..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
  30. ncbi Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
    Cherry L Estilo
    Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA
    BMC Cancer 9:11. 2009
    ..The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling...
  31. ncbi Thyroid incidentalomas: to treat or not to treat
    N G Iyer
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Arch Otorhinolaryngol 267:1019-26. 2010
    ..We propose a pragmatic algorithm when faced with this clinical dilemma under differing circumstances...
  32. ncbi TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome
    Eric J Sherman
    Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
    Laryngoscope 122:1043-50. 2012
    ..To develop and validate a simple prognostic tool that would help predict larynx preservation outcome...
  33. ncbi Thyroid and parathyroid surgery in pregnancy
    Randall P Owen
    Department of Surgery, Division of Metabolic, Endocrine and Minimally Invasive Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Eur Arch Otorhinolaryngol 267:1825-35. 2010
    ..In general, thyroid surgery can be delayed until after delivery except in cases of airway compromise or aggressive cancer. In contrast, parathyroid surgery is recommended during pregnancy to avoid adverse effects to the neonate...
  34. ncbi Factors predicting outcome in malignant minor salivary gland tumors of the oropharynx
    N Gopalakrishna Iyer
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 136:1240-7. 2010
    ..to report our experience in the care of patients with minor salivary gland cancers occurring only in the oropharynx and to determine factors predictive of outcome...
  35. ncbi FDG-PET detected thyroid incidentalomas: need for further investigation?
    Chandrakanth Are
    Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York, 10021, USA
    Ann Surg Oncol 14:239-47. 2007
    ..Incidental thyroid abnormalities are increasingly detected in patients undergoing PET scans. The aim of this study was to review our experience with the management of PET detected thyroid incidentalomas in a large single institution series...
  36. ncbi Management of mandibular invasion: when is a marginal mandibulectomy appropriate?
    Eric M Genden
    Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
    Oral Oncol 41:776-82. 2005
    ..The following is a review of the current literature regarding mandibular invasion and the indications for a marginal mandibulectomy...
  37. ncbi Referral guidelines for suspected cancer of the head and neck
    Eric M Genden
    Department of Otolaryngology and Head and Neck Surgery, The Mount Sinai School of Medicine, New York, NY, USA
    Auris Nasus Larynx 33:1-5. 2006
    ..CONCLUSION: Physician awareness and symptom guidelines may prove effective in expediting the care of patients with head and neck cancer...
  38. ncbi MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas
    Kepal N Patel
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 138:994-1001; discussion 1001-2. 2005
    ..Retrovirally delivered anti-MUC1 RNAi is effective in silencing MUC1 and merits further investigation to establish therapeutic efficacy and safety in anticipation of potential clinical application...
  39. ncbi Revision thyroid surgery - technical considerations
    Ashok R Shaha
    Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York, NY 10065, USA
    Otolaryngol Clin North Am 41:1169-83, x. 2008
    ..Despite good surgical resection, the incidence of local recurrence in the central compartment is high in patients undergoing reoperative thyroid surgery...
  40. ncbi Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Genes Chromosomes Cancer 40:355-64. 2004
    ..Our findings suggest a stronger relationship between the FVPTC and FTA/FTC than previously appreciated and support further consideration of the current classification of thyroid neoplasms...
  41. ncbi Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review
    Eric J Sherman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States
    Radiother Oncol 101:425-30. 2011
    ..We evaluated our more recent experience with this approach, which included pathologic confirmation of all cases...
  42. ncbi Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer
    Ashok R Shaha
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Laryngoscope 114:393-402. 2004
    ..The study describes the author's treatment approach related to the extent of thyroidectomy and adjuvant therapy based on various risk groups and the long-term survival...
  43. ncbi Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial
    David G Pfister
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:2565-70. 2010
    ..To determine whether acupuncture reduces pain and dysfunction in patients with cancer with a history of neck dissection. The secondary objective is to determine whether acupuncture relieves dry mouth in this population...
  44. ncbi Medical management of thyroid cancer: a risk adapted approach
    R Michael Tuttle
    Joan and Sanford I Weill Medical College of Cornell University, New York, New York 10021, USA
    J Surg Oncol 97:712-6. 2008
    ....
  45. ncbi Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members
    Ashok R Shaha
    Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Laryngoscope 116:1704-7. 2006
    ..However, its indications in adults remain unclear at this time...
  46. ncbi Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
    Luc G T Morris
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 20:153-8. 2010
    ..Our objective was to utilize a large cancer registry to obtain sufficient power to differentiate between outcomes in cases of TCV and PTC...
  47. ncbi Invited commentary: Vocal cord evaluation in thyroid surgery
    Ashok R Shaha
    Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Surgery 139:363-4. 2006
  48. ncbi Nutrition management of patients with malignancies of the head and neck
    James Paul O'Neill
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Surg Clin North Am 91:631-9. 2011
    ..In this article, the authors explore the nutritional requirements of these patients and the impact of a multidisciplinary therapeutic approach to head, neck, and skull base cancer care...
  49. ncbi Improved outcomes in patients with osteogenic sarcoma of the head and neck
    Snehal G Patel
    Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:1495-503. 2002
    ..The results of the current study represent a considerable improvement over the authors' previously published experience and compare favorably with the results reported in the literature...
  50. ncbi Hürthle cell carcinoma: a 60-year experience
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 9:197-203. 2002
    ..Recurrence portends a poor outcome. High-risk patients and those with recurrence should be considered for adjuvant therapy...
  51. ncbi Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer
    Benjamin D Rosenbluth
    Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 63:1419-26. 2005
    ..Ideal planning target volume doses have yet to be determined. Additional patients and long-term follow-up are needed to confirm these preliminary findings and to clarify late toxicities...
  52. ncbi Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma
    Kimberly M Dalal
    Division of Head and Neck Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 28:471-6. 2006
    ..The first patient subsequently underwent colonoscopy, which was negative for polyposis. CONCLUSIONS: Patients diagnosed with the cribriform-morular variant of papillary thyroid cancer should be screened for the presence of FAP...
  53. ncbi Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 64:3780-9. 2004
    ..3; 95% confidence interval, 1.1-5.5; P = 0.03). Our data suggest that MUC1 dysregulation is associated with aggressive behavior of PTC and may serve as a prognostic marker and potential therapeutic target in this disease...
  54. ncbi Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches
    Chandrakanth Are
    Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York 10021, USA
    Ann Surg Oncol 13:453-64. 2006
    ..We also reviewed the individual and combined roles of surgery, radiotherapy, chemotherapy, and newer therapeutic options in the management of ATC...
  55. ncbi Minimally invasive parathyroidectomy: the role of radio-guided surgery
    Ashok R Shaha
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Laryngoscope 112:2166-9. 2002
    ..Objectives were to review our current experience with radio-guided parathyroid surgery and to compare various techniques of minimally invasive parathyroidectomy...
  56. ncbi Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure
    Bhuvanesh Singh
    Laboratory of Epithelial Cancer Biology, Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, USA
    BMC Genet 3:22. 2002
    ..We used comparative genomic hybridization (CGH) to screen for the genetic aberrations in 71 patients with head and neck squamous cell carcinoma and stratified the findings by the status of tobacco/alcohol exposure...
  57. ncbi Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 34:54-64. 2003
    ..The molecular phenotype, p27(+)Bcl-2(+)Ki-67(-)mdm2(+), appears to be unique to nonmalignant parathyroid tumors, and multimarker phenotypes are more complex in carcinomas...
  58. ncbi Current management of tonsillar cancer
    Eric M Genden
    Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York, USA
    Oral Oncol 39:337-42. 2003
    ..While advanced lesions are often treated with a combination of radiation, chemotherapy, and surgical ablation, management of the neck and distant metastases continues to present a therapeutic dilemma...
  59. ncbi The role of operations for distantly metastatic well-differentiated thyroid carcinoma
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 131:636-43. 2002
    ..Complete metastasectomy may be associated with improved survival for localized distant disease. Palliative resection is indicated to improve quality of life for symptomatic distant metastasis...
  60. ncbi Prediction of survival in patients with head and neck cancer using the histoculture drug response assay
    Bhuvanesh Singh
    Head and Neck and Medical Oncology Services, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 24:437-42. 2002
    ..In this study, we have correlated the HDRA assessment with survival in patients with head and neck squamous cell carcinoma (HNSCC)...
  61. ncbi Parathyroid re-exploration
    Ashok R Shaha
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Otolaryngol Clin North Am 37:833-43, x. 2004
    ..This article discusses the issues the parathyroid surgeon must consider before and during re-operative surgery,with special attention to recently introduced adjunctive techniques...
  62. ncbi Primary mucosal malignant melanoma of the head and neck
    Snehal G Patel
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 24:247-57. 2002
    ..This study aims to assess the outcome and identify clinical and histologic prognostic indicators in a recent cohort of patients with MMHN treated at a single institution...
  63. ncbi Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas
    Bhuvanesh Singh
    Laboratory of Epithelial Cancer Biology, The Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Pathol 161:365-71. 2002
    ..6; 95% confidence interval = 1.9 to 29.6). The findings suggest that the 3q copy number status is an important marker for tumor progression and prognostication in patients with head and neck squamous cell carcinoma...
  64. ncbi Role of tracheal resection in thyroid cancer
    Natalya Chernichenko
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Curr Opin Oncol 24:29-34. 2012
    ..To provide a critical review of recent literature on the role of tracheal resection in thyroid cancer...
  65. ncbi Poorly differentiated and anaplastic thyroid cancer
    Kepal N Patel
    Department of Surgery, Stony Brook University Hospital, Stony Brook, New York, USA
    Cancer Control 13:119-28. 2006
    ..CONCLUSIONS: PDTC and ATC are rare diseases that carry a poor prognosis. Recognition of their different clinicopathologic features is important to the optimal management of these tumors...
  66. ncbi Medullary thyroid carcinoma
    Erik G Cohen
    Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Acta Otolaryngol 124:544-57. 2004
  67. ncbi Locally advanced thyroid cancer
    Kepal N Patel
    Head and Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Opin Otolaryngol Head Neck Surg 13:112-6. 2005
    ..The understanding and recognition of histopathological variations, such as poorly differentiated thyroid cancer is also important. New molecular markers are needed to help identify and predict aggressive tumor behavior...
  68. ncbi Treatment considerations for head and neck cancer in the elderly
    Eric M Genden
    Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY, USA
    J Laryngol Otol 119:169-74. 2005
    ..The aim of this review is to examine the current literature in an attempt to develop an approach to the treatment of the elderly patient with head and neck cancer and to define the pertinent issues that require further study...
  69. ncbi Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 9:789-98. 2002
    ..We identified factors predictive of outcome for recurrent differentiated thyroid carcinoma (DTC)...
  70. ncbi Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays
    Axel Hoos
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Am J Pathol 160:175-83. 2002
    ..Molecular alterations in the p53 pathway play a role in Hürthle cell tumorigenesis, but other unidentified molecular changes seem to be required to induce the malignant phenotype...
  71. ncbi Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cyst
    Snehal G Patel
    Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Surg Oncol 79:134-9; discussion 140-1. 2002
    ..Results of adequate excision using the Sistrunk operation are excellent and the concept of risk-groups should be used to identify patients, who would benefit from more aggressive treatment...
  72. ncbi Genome-wide appraisal of thyroid cancer progression
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, New York, New York 10021, USA
    Am J Pathol 161:1549-56. 2002
    ..Our data suggests that the development of chromosomal instability underlies the progression to more aggressive phenotypes of thyroid cancer and sheds light on the possible genomic aberrations that may be selected for during this process...
  73. ncbi Opening the "gift box": a systematic approach to expose the thyroid and superior thyroid vessels in complicated thyroid surgery
    Dimitrios Moraitis
    Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Surg Oncol 93:417-9. 2006
  74. ncbi Routine laryngoscopy in thyroid surgery: A valuable adjunct
    Ashok R Shaha
    Cornell University Medical Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 142:865-6. 2007
  75. ncbi Sentinel lymph node biopsy for cutaneous head and neck melanomas
    Snehal G Patel
    Head and Neck Service, PO Box 285, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Otolaryngol Head Neck Surg 128:285-91. 2002
    ..Although SLNB is a reliable indicator of the status of the draining lymphatic basins in CMHN, patients with negative SLNs must be observed for longer periods to understand the true implications of the procedure...
  76. ncbi Incidence of inadvertent parathyroid removal during thyroidectomy
    Derrick T Lin
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Laryngoscope 112:608-11. 2002
    ..Inadvertent parathyroidectomy did not result in symptomatic temporary or permanent hypocalcemia postoperatively...
  77. ncbi The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue
    Cherry L Estilo
    Dental Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 9:2300-6. 2003
    ..3 amplification. This study aimed to delineate the role of SCCRO and PIK3CA in the pathogenesis of oral tongue SCC...
  78. ncbi Pathology quiz case 2. Cutaneous angiosarcoma
    Kepal N Patel
    Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Arch Otolaryngol Head Neck Surg 130:1439, 1440-1. 2004
  79. ncbi Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism
    Benjamin L Judson
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Nucl Med 49:1813-8. 2008
    ..Nuclear imaging is also critical to the successful management of patients with persistent or recurrent hyperparathyroidism...
  80. ncbi Training in head and neck surgery and oncology
    Ashok R Shaha
    Cornell University Medical College, New York, New York 10065, USA
    J Surg Oncol 97:717-20. 2008
    ..The head and neck surgeon (leader of the orchestra) must be familiar with appropriate indications of each treatment modality and outcome. The head and neck surgeon of today should be an all-rounder...
  81. ncbi Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx
    Jeannette Marie S Matsuo
    Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Ann Surg 238:412-21; discussion 421-2. 2003
    ..CONCLUSION: Regardless of the index treatment modality, primary tumor site, or T stage, a higher clinical N stage at the time of presentation independently and significantly increases the risk of DM in patients with SCCL...
  82. ncbi Complications of neck dissection
    Eric M Genden
    Department of Otolaryngology--Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York, USA
    Acta Otolaryngol 123:795-801. 2003
  83. ncbi Current philosophy on the management of cancer of the base of the tongue
    Louis B Harrison
    Department of Radiation Oncology, Beth Israel Medical Center and St Luke's-Roosevelt Hospital Center, New York, NY, USA
    Oral Oncol 39:101-5. 2003
    ..This review provides an overview of the treatment options that exist, their advantages and disadvantages, and hopefully provides proper guidelines for the current management of this challenging disease...
  84. ncbi Surgical management of recurrent tumor in the neck
    Alfio Ferlito
    Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
    Acta Otolaryngol 122:121-6. 2002
  85. ncbi Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?
    Mohamed N Elsheikh
    Department of Otolaryngology-Head and Neck Surgery, Tanta University, Tanta, Egypt
    J Am Coll Surg 202:320-3. 2006
  86. ncbi Management of N3 neck
    Alfio Ferlito
    Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
    Acta Otolaryngol 122:230-3. 2002
  87. ncbi Is elective neck treatment indicated in patients with squamous cell carcinoma of the maxillary sinus?
    Alessandra Rinaldo
    Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
    Acta Otolaryngol 122:443-7. 2002
  88. ncbi Contemporary important considerations in diagnosis and treatment of head and neck cancer
    Alfio Ferlito
    Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
    Acta Otolaryngol 122:115-20. 2002
  89. ncbi Prospective functional voice assessment in patients undergoing thyroid surgery
    Alexander Stojadinovic
    Department of Surgery, Walter Reed Army Medical Center, Washington, D.C, USA
    Ann Surg 236:823-32. 2002
    ..Factors other than laryngeal nerve injury appear to alter post-thyroidectomy voice. The variability of patient symptoms underscores the importance of understanding the physiology of dysphonia...
  90. ncbi "Skip metastases" from head and neck cancers
    Alfio Ferlito
    Acta Otolaryngol 122:788-91. 2002
  91. ncbi New molecular diagnostic methods in head and neck cancer
    Juan Pablo Rodrigo
    Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
    Head Neck 27:995-1003. 2005
    ..However, despite the great promise of these new molecular approaches for cancer detection, much of the current technology limits their implementation into routine clinical use...
  92. ncbi Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?
    Robert Udelsman
    Yale University School of Medicine, PO Box 208062, New Haven, CT 06520-8062, USA
    Lancet Oncol 6:529-31. 2005
  93. ncbi Management of the N0 neck--reference or preference
    William I Wei
    Division of Head and Neck Surgery, Otorhinolaryngology, Plastic and Reconstructive Surgery, Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, Hong Kong, Peoples Republic of China
    Oral Oncol 42:115-22. 2006
    ....
  94. ncbi Neck dissection: then and now
    Alfio Ferlito
    Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
    Auris Nasus Larynx 33:365-74. 2006
    ..The authors conclude that neck dissection, as evolved over the past century, is a fundamental tool in management of patients with head and neck cancer, but is still a work in progress...
  95. ncbi Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma
    Patrick J Bradley
    Department of Otorhinolaryngology-Head and Neck Surgery, Queens Medical Centre, Nottingham, UK
    Eur Arch Otorhinolaryngol 263:889-94. 2006
    ..However, total laryngectomy may remain the only treatment option for advanced or aggressive first time recurrence, or in patients who develop subsequent recurrence following previous less aggressive surgery (endoscopic or external)...
  96. ncbi Elective and therapeutic selective neck dissection
    Alfio Ferlito
    Department of Surgical Sciences, ENT Clinic, University of Udine, Policlinico Universitario, Piazzale S Maria della Misericordia, 33100 Udine, Italy
    Oral Oncol 42:14-25. 2006
    ....
  97. ncbi Papillary microcarcinoma of the thyroid
    Ashok R Shaha
    J Surg Oncol 95:532-3. 2007
  98. ncbi Routine drainage after thyroid surgery--a meta-analysis
    Alvaro Sanabria
    Department of Surgery, Universidad de La Sabana, Bogota, Colombia
    J Surg Oncol 96:273-80. 2007
    ..In addition, the mean length of hospital stay was longer in the routine drainage group...
  99. ncbi Complications of neck dissection for thyroid cancer
    Ashok R Shaha
    Ann Surg Oncol 15:397-9. 2008
  100. ncbi Current management of mucosal melanoma of the head and neck
    Jesus E Medina
    Department of Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    J Surg Oncol 83:116-22. 2003
    ..A better grasp of the best means of treating MuM will likely come only when large referral centers are able to pool their experiences with these uncommon yet virulent malignancies...